Geoffrey Smith
InvestorManaging Partner at Digitalis Ventures Β· Board director at Grobio
New York, New York
Writes $100K β $10M checks Β· typically $1.5M
About
Geoffrey W. Smith combines biotech leadership as Alcea Therapeutics CEO with training physicians and scientists at Columbia, chairs Central European University, and founded Digitalis Commons for public-minded health innovation.
ContactΒ· self-published, not guessed
Invests in
AI & Machine LearningBiotechDeep TechDigital HealthHardwareHealthtechMedical Devices
Board director at Grobio
Intro paths
β
In turn, Geoffrey can intro founders to Grobio's investors below.
Grobio's investors Β· 8
Atlas VentureCambridge Β· $500K β $1M checks Β· since 2024Digitalis VenturesNew York Β· $100K β $10M checksDreamers VCEl Segundo Β· $500K β $5M checksInnovation EndeavorsPalo Alto Β· $1M β $15M checksLeaps by BayerLeverkusenOS FundPark Ridge Β· $1M β $2M checksREDMILESan FranciscoRising TidePacifica
Co-founders at Grobio
DJ
Daniel J MandellExecutive Officer, Director
Experience
- Digitalis VenturesFounder/Managing Partnercurrent2016 β presentNew York City Metropolitan Area
- Digitalis CommonsFounder/Chairmancurrent2019 β present
- Digitalis LabsFounder/Director of Researchcurrent2025 β presentNew York, New York, United States
- Partnership Fund for New York CityDirectorcurrent2026 β presentNew York, New York, United States
- Salzburg Global SeminarDirectorcurrent2024 β present
- The Jackson LaboratoryTrusteecurrent2017 β present
- Icahn School of Medicine at Mount SinaiDirector, Mount Sinai Institute of Technology2013 β 2014New York, NY
- Icahn School of Medicine at Mount SinaiProfessor, Population Health Science and Policy2012 β 2014New York, NY
- The Rockefeller UniversityVisiting Scholar2006 β 2014New York, New York, United States
Skills & more
Lifesciences27Biotechnology38Drug Discovery18Clinical Trials13Venture Capital51Management15Oncology4Infectious Diseases4Entrepreneurship12Technology Transfer7Pharmaceutical Industry4Cancer4
+9 more
CommercializationClinical DevelopmentCell BiologyGeneticsCell CultureLife SciencesStrategyStart-upsBusiness StrategyFrom Geoffrey's professional profile.
Colleagues at Digitalis Ventures
Amit Bansal
Partner at Digitalis Ventures
Ben Jacobs
Partner at Digitalis Ventures
Bo Stewart
Associate at Digitalis Ventures
Cindy Cole
Technical Partner at Digitalis Ventures
Dac Nguyen
Technical Partner at Digitalis Ventures
Drew Taylor
Partner at Digitalis Ventures
Dylan Henderson
Accounting Manager at Digitalis Ventures
Haiming Chen
Senior Accounting Manager at Digitalis Ventures
Network8
Ameena El-Bibany
Venture Partner at Page One Ventures
Amit Bansal
Partner at Digitalis Ventures
Charles K. Herman
Venture Partner at Digitalis Ventures
Chris Picardo
Partner at Madrona investing at the intersection of life science and computer science, plus consumer tech and Web3
Cindy Cole
Technical Partner at Digitalis Ventures
Dac Nguyen
Technical Partner at Digitalis Ventures
Drew Taylor
Partner at Digitalis Ventures
Gaurav Tewari
Investor at Omega Venture Partners
Investors connected to Geoffrey in public investor directories β a warm-intro map.
Frequently asked questions
- Who is Geoffrey Smith?
- Geoffrey W. Smith combines biotech leadership as Alcea Therapeutics CEO with training physicians and scientists at Columbia, chairs Central European University, and founded Digitalis Commons for public-minded health innovation.
- Where does Geoffrey Smith work?
- Geoffrey Smith is Managing Partner at Digitalis Ventures and Board director at Grobio.
- What does Geoffrey Smith invest in?
- Geoffrey Smith invests in AI & Machine Learning, Biotech, Deep Tech, Digital Health, Hardware, Healthtech, Medical Devices.
- What check size does Geoffrey Smith write?
- Geoffrey Smith typically writes checks of $100K β $10M.
- Where did Geoffrey Smith go to school?
- Geoffrey Smith studied at University of Pennsylvania (Doctor of Law (J.D.)); Williams College (Bachelor of Arts (B.A.)).
Same school
Also attended University of Pennsylvania824
Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC Partners
+ 818 more
Also attended Williams College102
Chase ColemanFounder & Partner of Tiger Global ManagementSteve CaseChairman & CEO of Revolution; co-founder of AOLChris PicardoPartner at Madrona investing at the intersection of life science and computer science, plus consumer tech and Web3Isabelle PhelpsPartner at Lerer HippeauNino MarakovicPartner, CEO at Sapphire VenturesAlex MarshallPartner & General Counsel at Generation Investment Management
+ 96 more
Shared employers
Also worked at Digitalis Commons5
Also worked at The Jackson Laboratory11
Stacey HeroInvestor at Third Rock VenturesEric HorvitzInvestor at Blue Tulip VenturesCarla BrodleyInvestor at Blue Tulip VenturesGregInvestor at Quorum Capital PartnersShannon BeanPrincipal at CEI VenturesBenjamin ShawPartner at Borealis Ventures
+ 5 more
Also worked at Icahn School of Medicine at Mount Sinai20
Justin RobenyAssociate at Osage University PartnersSylvain SachotPartner at Asabys PartnersTeri WilleyP2C Managing Director & Officer at Pathway to CuresAvidan RudanskyInvestor at Maccabee VenturesJoel DudleyVenture Partner at Innovation EndeavorsAlejo ChornyPrincipal Investment at Criteria Bio Ventures
+ 14 more
Also worked at The Rockefeller University18
Mojca SkoberneEntrepreneur in Residence at GV (Google Ventures)Hani GoodarziFounder, Tahoe Therapeutics at Amplify PartnersMira ChaurushiyaManaging Director at Westlake Village BioPartnersEli CasdinChief Investment Officer and Founder at Casdin CapitalMay HanPartner at Cure VenturesBeccaInvestor at Sanofi Ventures
+ 12 more






















































